Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine

Palliative Medicine

Volumn 15, Issue 1, 2001, Pages 26-34

  Lee, Mark A ^a   Leng, Mhoira E F ^a   Tiernan, Eóin J J ^a  

^a Department of Palliative Medicine ^*  (United Kingdom)

Author keywords

Hydromorphone; Metabolites; Palliative care; Renal impairment; Side effects

Indexed keywords

CREATININE; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DIAMORPHINE; DICONAL; ELECTROLYTE; FENTANYL; HYDROMORPHONE; KETAMINE; METHADONE; MORPHINE; OPIATE; TRAMADOL; UREA;

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NAUSEA; OUTCOMES RESEARCH; PALLIATIVE THERAPY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CREATININE; FEMALE; HUMANS; HYDROMORPHONE; KIDNEY; MALE; MIDDLE AGED; MORPHINE; PALLIATIVE CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UREA;

EID: 0035142241     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/026921601669626431     Document Type: Article

References (28)

1. Cancer pain and palliative care
2. Comparative clinical efficacy of immediate release and controlled release hydromorphone for chronic severe cancer pain
3. Opioid rotation for toxicity reduction in terminal cancer patients
4. Palliative care formulary
5. Hydromorphone metabolite accumulation in renal failure
6. Urinary excretion of hydromorphone and metabolites in humans, rats, dogs, guinea pigs, and rabbits
7. Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone
8. Hydromorphone-3-glucuronide: Biochemical synthesis and preliminary pharmacological evaluation
9. Clonazepam treatment of myoclonic contractions associated with high-dose opioids: Case report
10. Multifocal myoclonus and seizures in extremely high-dose opioid administration
11. Putative role of hydromorphone metabolites in myoclonus
12. Individual variability in the response to different opioids: Report of five cases
13. Differences in efficacy between morphine and methadone demonstrated in the guinea pig ileum
14. Evaluation of receptor mechanisms mediating fentanyl analgesia and toxicity
15. Dose ratio between morphine and hydromorphone in patients with cancer pain: A retrospective study
16. Opioid rotation in patients with cancer pain
17. Pharmacokinetics of opioids in renal dysfunction
18. Pharmacokinetics and pharmacodynamics of codeine in end-stage renal disease
19. Studies on morphine disposition: Influence of renal failure on the kinetics of morphine and its metabolites
20. The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantations
21. Morphine intoxication in renal failure: The role of morphine-6-glucuronide
22. Chronic nausea and morphine-6-glucuronide
23. Clinical physiology of the kidney: Tests of renal function and structure
24. Serum creatinine is a poor marker of glomerular filtration rate in patients with spina bifida
25. 131I-hippuran clearance and estimated creatinine clearance in cancer patients
26. Measurement of the glomerular filtration rate